Equities

Shanghai Shyndec Pharmaceutical Co Ltd

600420:SHH

Shanghai Shyndec Pharmaceutical Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)12.90
  • Today's Change0.33 / 2.63%
  • Shares traded47.81m
  • 1 Year change+26.97%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of CNY
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments5,8926,0904,157
Total Receivables, Net2,1862,7733,333
Total Inventory2,2802,4403,072
Prepaid expenses212324196
Other current assets, total8859128
Total current assets10,65711,68410,886
Property, plant & equipment, net6,0456,3536,670
Goodwill, net160160160
Intangibles, net814733676
Long term investments1,489440442
Note receivable - long term------
Other long term assets5.918.0429
Total assets19,35219,63019,070
LIABILITIES
Accounts payable9539611,089
Accrued expenses350379364
Notes payable/short-term debt7188482,704
Current portion long-term debt/capital leases1158590
Other current liabilities, total1,7481,9492,095
Total current liabilities3,7804,1966,843
Total long term debt1,0893,0241,590
Total debt1,8173,9304,884
Deferred income tax22120126
Minority interest1,9501,8471,777
Other liabilities, total123139141
Total liabilities6,9649,32510,477
SHAREHOLDERS EQUITY
Common stock1,3411,1721,027
Additional paid-in capital5,2043,5872,545
Retained earnings (accumulated deficit)5,8455,2874,762
Treasury stock - common------
Unrealized gain (loss)0.05(0.04)(0.53)
Other equity, total(1.14)259259
Total equity12,38810,3058,593
Total liabilities & shareholders' equity19,35219,63019,070
Total common shares outstanding1,3411,1721,027
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.